$IBRX

$8.63 +$0.82 (10.5%) Close

$IBRX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 1.06B shares outstanding

Who owns IBRX?

By type of holder

Institutions 19.0% Insiders 7.0% Everyone else 74.0%

Concentration Top 10 holders own 37.0%

Cambridge Equities, LP 24.7% · BlackRock, Inc. 3.2%

Institutional ownership

19.0%

+2.2 pts vs last qtr

Institutional holders

402

+17 vs last qtr

Net shares bought

+23.2M

by institutions in Q2 2026

New / sold out

65 / 48

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

BlackRock, Inc. +7.7M
Two Sigma Investments, LP +6.7M

Biggest sellers in Q2 2026

HRT Financial LP SOLD OUT −3.9M
Private Advisor Group, LLC −1.5M

Who is planning to sell?

Notices of proposed sale, last 12 months

$21.3M

11 notices from 4 people

Shares covered

2.0M

0.19% of the company

Arranged in advance

100%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Simon Barry J. Officer 10b5-1 $16.5M
Christobel Selecky Director 10b5-1 $2.79M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2019–FY2025

+151.1%

+16.59% a year

Each share's claim on the business

−60.2%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

$2.5M vs $223M

over 7 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years67% 3–5 years1% 1–3 years15% Under 1 year17%

Quarterly turnover

17.3%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting IBRX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	34.1M	3.22%	+7.7M (+29.4%)	≤2021	0.0%
Shares held by quarter Peak holding34.1M (Q2'26) Change over 8 quarters+22.2M Share of the company3.220% BlackRock, Inc.'s full portfolio →
SS State Street Corp	21.4M	2.02%	+3.7M (+20.8%)	≤2021	0.0%
Shares held by quarter Peak holding21.4M (Q2'26) Change over 8 quarters+12.7M Share of the company2.020% State Street Corp's full portfolio →

BlackRock, Inc.

34.1M

% of company

3.22%

Change vs last qtr

+7.7M (+29.4%)

Held since

≤2021

State Street Corp

21.4M

% of company

2.02%

Change vs last qtr

+3.7M (+20.8%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding ImmunityBio, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting IBRX on Form N-PORT; together they hold 8.3% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
SS State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR Series Trust	$109M	12.5M	1.18%	1.02%	June 30, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$102M	11.6M	1.09%	0.00%	June 30, 2026

State Street(R) SPDR(R) S&P(R) Biotech ETF

SPDR Series Trust

Position value

$109M

% of company

1.18%

% of the fund

1.02%

As of

June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$102M

% of company

1.09%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding ImmunityBio, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
CE Cambridge Equities, LP 5%+ holder 13D · 24.7%	261.7M	24.69%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company24.690% Disclosed stake13D · 24.7% View the 13D/G filing →
SB Simon Barry J. Insider	2.8M	0.26%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.260% Simon Barry J.'s insider activity →

Cambridge Equities, LP

5%+ holder13D · 24.7%

261.7M

% of company

24.69%

Change vs last qtr

—

Held since

—

Simon Barry J.

Insider

2.8M

% of company

0.26%

Change vs last qtr

—

Held since

—

4 more holders behind a free account

See every insider and 5%+ holder of ImmunityBio, Inc..

Comments